Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.
AUTOR(ES)
Simor, A E
RESUMO
The in vitro susceptibilities of 56 clinical isolates of Campylobacter pylori to six new fluoroquinolones and other oral antimicrobial agents were determined by an agar dilution technique. Ciprofloxacin was the most active of the fluoroquinolones (MIC for 90% of strains tested [MIC90], 0.05 microgram/ml). Other fluoroquinolones had variable activities, although most isolates were moderately susceptible to fleroxacin (MIC90, 4 micrograms/ml) and lomefloxacin (MIC90, 4 micrograms/ml).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=171430Documentos Relacionados
- In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.
- Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species.
- Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae.
- Comparative in vitro activities of pristinamycin and other antimicrobial agents against genital pathogens.
- In vitro activities of new quinolones against Helicobacter pylori.
